Cite

HARVARD Citation

    Zammarchi, F. et al. (2020). CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record